MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
139 hedge funds and large institutions have $703M invested in Merrimack Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 35 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 139 → 139 (0)
0% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 19
Holders
139
Holding in Top 10
2
Calls
$2.91M
Puts
$1.49M
Top Buyers
| 1 | +$49.2M | |
| 2 | +$7.29M | |
| 3 | +$5.33M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$3.78M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$3.16M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$9M | |
| 3 | -$4.21M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.87M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$3.23M |